Quality of Life shown in robust Q1 for Thermo Fisher
Q1 revenues for Thermo Fisher’s Life Sciences Solutions business shot up 384% year-over-year in a quarter that saw the integration of Life Technologies.
Archives for April 22, 2014
US FDA offers guidance on when two mAbs should be considered the same
As the race to develop mAbs (monocolonal antibodies) heats up and companies vie for the elusive seven years exclusivity that comes with an orphan drug designation, the US FDA is now offering guidance on when two mAbs should be viewed as the same.
Epirus hopes to bring its infliximab biosimilar to EU in merger with Zalicus
Epirus and Zalicus have agreed to merge in order to focus on the development and manufacture of biosimilars.
Generation of biobetters could push out biosimilar development, says expert
The latest generation of “biobetters” which are engineered to be more effective than branded biologics are hitting the market before biosimilars and could make development of the latter pointless, an expert has said.